• Aurora Cannabis Inc ACB.TO reported quarterly adjusted earnings of 58 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -50 cents. The mean expectation of two analysts for the quarter was for a loss of 10 cents per share. Wall Street expected results to range from -18 cents to -3 cents per share.

• Revenue rose 36.9% to C$88.20 million from a year ago; analysts expected C$78.30 million.

• Aurora Cannabis Inc's reported EPS for the quarter was 58 cents​.

• The company reported quarterly net income of C$31.02 million.

• Aurora Cannabis Inc shares had fallen by 13.4% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 19.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is "hold."

Wall Street's median 12-month price target for Aurora Cannabis Inc is $32.00

This summary was machine generated from LSEG data February 5 at 02:31 p.m. UTC. ​All figures in Canadian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)